Creatine supplementation in women's health: a lifespan perspective
Open accessThe DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index; 5 of the 70 sources its claims cite were checked for support.
Abstract
Despite extensive research on creatine, evidence for use among females is understudied. Creatine characteristics vary between males and females, with females exhibiting 70–80% lower endogenous creatine stores compared to males. Understanding creatine metabolism pre- and post-menopause yields important implications for creatine supplementation for performance and health among females. Due to the hormone-related changes to creatine kinetics and phosphocreatine resynthesis, supplementation may be particularly important during menses, pregnancy, post-partum, during and post-menopause. Creatine supplementation among pre-menopausal females appears to be effective for improving strength and exercise performance. Post-menopausal females may also experience benefits in skeletal muscle size and function when consuming high doses of creatine (0.3 g·kg−1·d−1); and favorable effects on bone when combined with resistance training. Pre-clinical and clinical evidence indicates positive effects from creatine supplementation on mood and cognition, possibly by restoring brain energy levels and homeostasis. Creatine supplementation may be even more effective for females by supporting a pro-energetic environment in the brain. The purpose of this review was to highlight the use of creatine in females across the lifespan with particular emphasis on performance, body composition, mood, and dosing strategies.
Overview
CoChat Summary
TL;DR
This narrative review synthesizes evidence on creatine supplementation in females across the lifespan, focusing on performance, body composition, mood, cognition, and dosing. It concludes that creatine is generally safe and may offer particular benefits during hormonal transitions, but female-specific and long-term data remain limited.
Key findings
- Females exhibit 70–80% lower endogenous creatine stores than males; premenopausal creatine supplementation improves strength and power without marked body-weight changes. For example, 10 weeks of creatine monohydrate (CrM) increased 1RM leg press, leg extension, and squat by 20–25% more than placebo, and in female soccer players increased bench press and squat 1RM by 18% and 24% versus 9% and 12% with placebo.
- Postmenopausal females may benefit from short-term high-dose creatine (0.3 g·kg−1·d−1 or ~20 g·d−1 for 7 days), which augmented whole-body fat-free mass (0.52 ± 0.05 kg), leg press strength (5.2 ± 1.8 kg), bench press strength (1.7 ± 0.4 kg), and sit-stand/tandem gait performance. Combined with resistance training, CrM (≥5 g·d−1) generally improved muscle accretion, strength, and physical function, though bone effects were mixed or absent.
- Mood and cognition evidence includes a decline in mean Children’s Depression Rating Scale-Revised score from 69 to 30.6 (56% decrease) in adolescent females taking 4 g CrM daily for 8 weeks with antidepressants, and greater Hamilton Depression Rating Scale improvements after 2 weeks with 5 g·d−1 for 8 weeks. Adults in the lowest quartile of dietary creatine intake had a 31% greater incidence of depression.
- Dosing: a loading phase increases total muscle creatine concentrations by 19% in females; 0.3 g·kg−1·d−1 for 5–7 days or 5 g·d−1 for 4 weeks can be effective, while brain saturation may require 15–20 g·d−1 for 3–7 days followed by 5–10 g·d−1.
Methods
- Narrative review of creatine supplementation in females from young adulthood to old age, with no new primary data collection.
- Synthesizes human trials and preclinical/animal evidence on exercise performance, body composition, pregnancy, post-menopause, mood, cognition/sleep, and dosing strategies.
- Includes relative-effect calculations from cited studies using the equation RE = ((PostCr/PreCr) × 100 / (PostPL/PrePL) × 100) × 100, where values >100 indicate improvement with creatine.
Limitations
- Stated: female-specific evidence is understudied; there are no human studies evaluating CrM supplementation during pregnancy; individual variability (responders, quasi-responders, non-responders) has not yet been explored in females; future longer-term randomized placebo-controlled trials with large sample sizes are needed for musculoskeletal outcomes.
- Stated in cited studies: some trials lacked a placebo group, had non-responders, used insufficient loading doses or training volumes, or enrolled participants with higher baseline intramuscular creatine; not all studies show additive effects of CrM on strength or body composition.
- Evident: as a narrative review, no systematic search strategy, risk-of-bias assessment, or meta-analysis is described, and conclusions rely on heterogeneous studies plus extrapolation from animal and preclinical data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 A theoretical model for the interplay between creatine kinase and menstrual cycle hormones [6,10,11]. Creatine metabolism and creatine kinase concentrations vary throughout the menstrual cycle and lifecycle. These alterations may also influence metabolic characteristics of protein and carbohydrate oxidation [12], which provides a physiological basis for the potential use of creatine supplementation for females.](https://figures.cochat.ai/paper-figures/01069dfc06344ff98e1c48099e2bc6c4/creatine-supplementation-in-women-s-health-a-lifespan-perspective-figure-1.jpg)



Verification
Claims the paper makes
3 Valid · 4 Not valid · 56 Not checked · 31 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“When combined with regular antidepressant use, 8-weeks of CrM supplementation reduced depressive symptoms in female adolescents and adults with major depression [86,87,88].”
§ Creatine Supplementation in Women’s Health: A Lifespan Perspective > 6. Depression and Mood
What the sources say
- Supportedcites [86] Hellem T.L. Sung Y.H. Shi X.F. Pett M.A. Latendresse G. Morgan J. Huber R.S. Kuykendall D. Lundberg K.J. Renshaw P.F. Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study J. Dual. Diagn. 2015 11 189 202 10.1080/15504263.2015.1100471 26457568 PMC4684979 source
The Introduction states that 'adjunctive oral creatine use has been associated with reduced depressive symptoms in female adolescents (Kondo et al., 2011) and adults (Lyoo et al., 2012) taking an SSRI,' and the Discussion adds that Lyoo (2012) and Kondo (2011) 'noted decreased HAMD and Children's Depression Rating Scale-Revised (CDRS-R) scores... as early as the second week of 8 weeks of creatine augmentation' — covering the population (female adolescents and adults with major depression), the antidepressant combination, the 8-week duration and the reduction in depressive symptoms. Our copy reports these as the results of Kondo et al. (2011) and Lyoo et al. (2012) rather than as this pilot study's own trial, which was an 8-week open-label 5 g/day creatine study in 14 adult females (18–64 years) with major depressive disorder and comorbid methamphetamine dependence (Methods, Participants; Discussion). The cited sentence carries three references, so this source is offered alongside the original trials, not as the sole original study. (LLM, conf=0.82)
- Disputedcites [87] Kondo D.G. Forrest L.N. Shi X. Sung Y.H. Hellem T.L. Huber R.S. Renshaw P.F. Creatine target engagement with brain bioenergetics: A dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression Amino Acids 2016 48 1941 1954 10.1007/s00726-016-2194-3 26907087 PMC4974294 sourceExperimental — accuracy not yet measured
Our copy's own trial — a placebo-controlled, dose-ranging 8-week study of adjunctive creatine monohydrate in adolescent females with SSRI-resistant MDD — reports in the Results (Fig. 6 discussion) that 'We did not find a statistically significant between-group difference in CDRS-R scores at week 8 (p = 0.59), nor does the change in depression score appear to be dose-dependent,' and the Discussion repeats that the 2 g group's apparent clinical response 'was not statistically significant (p = 0.59).' The Abstract frames the outcome as target engagement (frontal lobe PCr +4.6/+4.1/+9.1 % vs placebo -0.7 %) with the depression link expressed only as an inverse correlation of PCr with CDRS-R scores (p = 0.02), not as symptom reduction versus placebo. The positive symptom-reduction findings the claim rests on are credited within the paper to other works it cites — Lyoo et al. 2012 (unmedicated adult females with MDD added to escitalopram, greater improvement from week 2) and Kondo et al. 2011b (open-label adolescent females, mean 56 % CDRS-R reduction after 8 weeks of 4 g CM) — so this source does not support the attributed claim and states a contrary clinical result for its own 8-week adolescent trial. (LLM, conf=0.75)
Checked by a reasoning model — may be wrong.
- Not checked yetcites [88] Lyoo I.K. Yoon S. Kim T.S. Hwang J. Kim J.E. Won W. Bae S. Renshaw P.F. A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder Am. J. Psychiatry 2012 169 937 945 10.1176/appi.ajp.2012.12010009 22864465 PMC4624319 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“the CrM group demonstrating greater improvements in jump and repeated sprint performance tests, indicating that adaptations to plyometric training were enhanced with CrM supplementation.”
§ Creatine Supplementation in Women’s Health: A Lifespan Perspective > 3. Creatine Use among Pre-Menopausal Women > 3.2. Effect of Creatine on Exercise Performance
What the sources say
- Supportedcites [38] Ramirez-Campillo R. Gonzalez-Jurado J.A. Martinez C. Nakamura F.Y. Penailillo L. Meylan C.M. Caniuqueo A. Canas-Jamet R. Moran J. Alonso-Martinez A.M. Effects of plyometric training and creatine supplementation on maximal-intensity exercise and endurance in female soccer players J. Sci. Med. Sport 2016 19 682 687 10.1016/j.jsams.2015.10.005 26778661 source
The Results (p. 8 of our copy) report that both plyometric groups improved, but only the CREATINE group showed greater meaningful training effects on squat jump, 40-cm drop jump reactive strength index and peak jump power load, and on RAST mean sprint times versus PLACEBO and CONTROL; the Discussion repeats this for jump and repeated-sprint outcomes. The Conclusions state directly that in female soccer players 'the improvements induced by plyometric training were enhanced by creatine supplementation', matching the claim's population, intervention and outcomes. The Discussion and Practical Implications hedge slightly ('may boost further adaptations', 'might be enhanced'), but the paper's own conclusion asserts the enhancement, so the un-hedged paraphrase is not an overstatement of the source. (LLM, conf=0.90)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Supplementing with CrM can be accomplished using two strategies, both resulting in similar increases in intramuscular PCr levels (Table 1) [7].”
§ Creatine Supplementation in Women’s Health: A Lifespan Perspective > 8. Dosing Strategies
What the sources say
- Partly supportedcites [7] Kreider R.B. Kalman D.S. Antonio J. Ziegenfuss T.N. Wildman R. Collins R. Candow D.G. Kleiner S.M. Almada A.L. Lopez H.L. International Society of Sports Nutrition position stand: Safety and efficacy of creatine supplementation in exercise, sport, and medicine J. Int. Soc. Sports Nutr. 2017 14 18 10.1186/s12970-017-0173-z 28615996 PMC5469049 sourceExperimental — accuracy not yet measured
The 'Supplementation protocols' section does describe two CrM strategies — a loading protocol (5 g four times daily, ~0.3 g/kg/day, for 5–7 days) followed by 3–5 g/day maintenance, and an alternative of 3 g/day for 28 days (echoed in the Position statement: 3–5 g/day raising stores over 3–4 weeks) — and both are said to raise muscle creatine and PCr by 20–40% toward full saturation. However, our copy never states that the two produce 'similar increases in intramuscular PCr'; it instead stresses that the low-dose method yields only a gradual increase relative to rapid loading and 'may therefore have less effect on exercise performance and/or training adaptations until creatine stores are fully saturated.' The equivalence-of-magnitude claim attributed here is thus implied at best (both eventually saturate stores) but not asserted by the source. (LLM, conf=0.72)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Skeletal muscle creatine uptake can also be influenced by insulin availability, which may enhance creatine retention [103,104].”
§ Creatine Supplementation in Women’s Health: A Lifespan Perspective > 8. Dosing Strategies
What the sources say
- Not checked yetcites [103] Green A.L. Simpson E.J. Littlewood J.J. Macdonald I.A. Greenhaff P.L. Carbohydrate ingestion augments creatine retention during creatine feeding in humans Acta Physiol. Scand. 1996 158 195 202 10.1046/j.1365-201X.1996.528300000.x 8899067 source
- Supportedcites [104] Steenge G.R. Lambourne J. Casey A. Macdonald I.A. Greenhaff P.L. Stimulatory effect of insulin on creatine accumulation in human skeletal muscle Am. J. Physiol. 1998 275 E974 E979 10.1152/ajpendo.1998.275.6.E974 9843739 source
The Discussion (p. E974/E976 region) states the study's aim was 'to examine the relationship between insulin availability and muscle creatine accumulation in humans' and reports that 'insulin augmented muscle creatine accumulation but only when present at high (~100 mU/l) or supraphysiological (~200 mU/l) concentrations,' with lower plasma creatine under those clamps indicating increased muscle creatine transport. The Conclusion (E977) reiterates that 'insulin can enhance muscle creatine accumulation in human skeletal muscle.' The citing sentence is hedged ('may enhance creatine retention'), so it is not stronger than the source; the only nuance the source adds is that the effect required high/supraphysiological insulin, which the citing sentence does not overstate. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Short-term CrM supplementation has also been shown to significantly increase muscular power in females.”
§ Creatine Supplementation in Women’s Health: A Lifespan Perspective > 3. Creatine Use among Pre-Menopausal Women > 3.1. Creatine Supplementation and Strength Performance
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
57 more claims
Create a free account to see all 94 claims and to verify the 64 references still open.
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The uncertainty may largely be impacted by the timing of measurements around the menstrual cycle, which have not been previously accounted for and may have influenced the results”
From Creatine O'Clock: Does Timing of Ingestion Really Influence Muscle Mass and Performance? (2022) · cites this paper as Smith-Ryan et al., 2021
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“no sex sub-analysis was made in the Candow et al. (2014b) or Forbes et al. (2021b) studies which may have influenced their findings”
From Creatine O'Clock: Does Timing of Ingestion Really Influence Muscle Mass and Performance? (2022) · cites this paper as Smith-Ryan et al., 2021
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Proctor and colleagues investigated grip strength and force development in 13 post-menopausal women using a double-blind randomized design and found that NO3− supplementation enhanced force development and increased time to fatigue [305].”
From International society of sports nutrition position stand: nutritional concerns of the female athlete (2023) · cites this paper as [305]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This study highlights the potential efficacy of NO3− supplementation in postmenopausal women”
From International society of sports nutrition position stand: nutritional concerns of the female athlete (2023) · cites this paper as [305]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Creatine Supplementation in Women’s Health: A Lifespan Perspective > 9. Conclusions and Application
“A traditional loading dose (0.3 g∙day−1 5–7 days) or a routine daily dose (5 g) for 4 weeks can be effective for females.”
§ Creatine Supplementation in Women’s Health: A Lifespan Perspective > 5. Creatine Considerations for Post-Menopausal Women > 5.1. Supplementation Only
“a short-term, high dose creatine loading period (0.3 g·kg−1·d−1 or ~20 g·d−1 for 7 days)”
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950 · cited 1×
“Sex hormones, predominantly estrogen and progesterone, have been shown to effect creatine kinase activities and the expression of key enzymes for the endogenous synthesis of creatine [10].”
BackgroundWallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., & Eppenberger, H. M. (1992) · Biochemical Journal · doi:10.1042/bj2810021 · Cited by 2,011 · cited 1×
“Previous research has shown that dietary creatine supplementation can promote cell survival and influence the production and usage of energy in the brain [3,82].”
BackgroundGender differences in stress and coping styles
Matud, M. P. (2004) · Personality and Individual Differences · doi:10.1016/j.paid.2004.01.010 · Cited by 1,880 · cited 1×
“Females process stress different than males [97], often practicing more frequent habits of multi-tasking [98] and are also more often susceptible to sleep deprivation due to pregnancy, post-partum demands, and menopausal sleep disturbances.”
BackgroundWhy is depression more prevalent in women?
Albert, P. R. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.150205 · Cited by 1,785 · cited 1×
“The increased prevalence of depression among females has been directly linked with hormonal milestones; major depression rates increase during puberty, during the luteal (high estrogen) phase, following pregnancy, and during perimenopause [75].”
BackgroundElevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation
Harris, R. C., Söderlund, K., & Hultman, E. (1992) · Clinical Science · doi:10.1042/cs0830367 · Cited by 1,168 · cited 3×
“A loading phase in females results in a 19% increase in total muscle creatine concentrations [67,101], which is similar to the response for males.”
BackgroundResultKreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057 · cited 5×
“The current body of literature that has evaluated the effect of creatine supplementation in females suggests that the risk-to-benefit ratio is low [7], with most studies indicating that there are numerous metabolic, hormonal, and neurological benefits.”
BackgroundMethodResultInfluentialTrends in dietary supplement use among US adults from 1999-2012.
Kantor, E. D., Rehm, C. D., Du, M., White, E., & Giovannucci, E. L. (2016) · JAMA · doi:10.1001/jama.2016.14403 · Cited by 644
Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis
Greenhaff, P. L., Bodin, K., Soderlund, K., & Hultman, E. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.5.e725 · Cited by 531 · cited 3×
“This recycling also serves as an endogenous metabolic buffer helping to maintain pH [2], and both mechanisms can support cross-bridge recycling and energy availability during exercise.”
BackgroundCreatine: Biosynthesis, Regulation, and Function
Walker, J. B. (1979) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470122952.ch4 · Cited by 496 · cited 2×
“Studies conducted in animal mod ls have demo stra d that th expr s io of arginine-glycine aminotransferase (AGAT), the rate limiting step of creatine synthesis, is influenced by estrogen and testosterone levels [9].”
BackgroundBrain Metabolic Alterations in Medication-Free Patients With BipolarDisorder
Dager, S. R., Friedman, S. D., Parow, A., Demopulos, C., Stoll, A. L., Lyoo, I. K., Dunner, D. L., & Renshaw, P. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.5.450 · Cited by 453 · cited 1×
“The severity of a depressive episode has been inversely linked to white matter creatine and PCr concentrations within the brain suggesting that there is a relationship between brain creatine metabolism and depression [79].”
Background
Cited by
Sarcopenia in Menopausal Women: Current Perspectives
Buckinx, F., & Aubertin‐Leheudre, M. (2022) · International Journal of Women s Health · doi:10.2147/ijwh.s340537 · Cited by 173
International society of sports nutrition position stand: nutritional concerns of the female athlete
Sims, S. T., Kerksick, C. M., Smith-Ryan, A. E., Janse de Jonge, X. A. K., Hirsch, K. R., Arent, S. M., Hewlings, S. J., Kleiner, S. M., Bustillo, E., Tartar, J. L., et al. (2023) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2023.2204066 · Cited by 129
“every 4 hours), followed by 3-5 g per day [306].”
BackgroundThe musculoskeletal syndrome of menopause
Wright, V. J., Schwartzman, J. D., Itinoche, R., & Wittstein, J. (2024) · Climacteric · doi:10.1080/13697137.2024.2380363 · Cited by 133
Kreider, R. B., Jäger, R., & Purpura, M. (2022) · Nutrients · doi:10.3390/nu14051035 · Cited by 103
“A recent Special Issue on creatine supplementation for health and clinical diseases overviewed the metabolic basis of creatine in health and disease [5] and potential health and/or therapeutic benefits of CrM supplementation for pregnancy and newborn health [146], children and adolescents [147–151], physically active…”
Background“Heads up” for creatine supplementation and its potential applications for brain health and function
Candow, D. G., Forbes, S. C., Ostojic, S. M., Prokopidis, K., Stock, M. S., Harmon, K. K., & Faulkner, P. (2023) · Sports Medicine · doi:10.1007/s40279-023-01870-9 · Cited by 78
“…creatine stores [8], which may subsequently blunt their responsiveness to creatine supplementation [9]; no decrease in measures of muscle protein catabolism from creatine supplementation over time [10, 11]; and the possible influence that fluctuations in estrogen have on creatine homeostasis [5].”
Background
Metadata
- Authors
- Smith-Ryan, A. E., Cabre, H. E., Eckerson, J. M., & Candow, D. G.
- Affiliations
- Applied Physiology Laboratory, Department of Exercise and Sport Science, University of North Carolina at Chapel Hill, Chapel Hill, NC 27713, USA
- University of North Carolina at Chapel Hill (US)
- Creighton University (US)
- University of Regina (CA)
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2021-03-08
- Volume
- 13
- Issue
- 3
- Pages
- 877
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7998865
- OpenAlex
- W3135692987
- Cited by
- 92
- References
- 112
- Citations by year
- 2026: 26 · 2025: 21 · 2024: 18 · 2023: 13 · 2022: 11 · 2021: 3
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Sports Performance and Training
- Keywords
- creatine supplementation, women's health, sex differences, menopause, phosphocreatine resynthesis, exercise performance, resistance training, postpartum period, pregnancy, bone health, mood, cognition, brain energy metabolism, body composition
- MeSH terms
- Adult, Affect, Aged, Body Composition, Brain, Creatine, Female, Humans, Longevity, Menopause, Middle Aged, Phosphocreatine, Exercise, Women's Health, Muscle, Skeletal, Dietary Supplements, Resistance Training
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.